Angel Acquisitions, Inc. Changes Name to BioGeron, Inc.

BioGeron Brings Its First Product, Super Krill, to Market


CARSON CITY, NV--(Marketwire - December 6, 2010) - Angel Acquisitions Corp. (OTCBB: AGEL) announced today that the Board of Directors has approved a name change to BioGeron, Inc. The Company will apply immediately for a symbol change and transfer its website and other corporate identification in the coming days.

In response to a widespread acceptance by consumers and retailers of BioGeron's new line of bio-nutraceutical products, the decision was made to exclusively focus the company's energy and resources on the bio-nutraceutical marketplace. BioGeron is a manufacturer of premier nutraceutical products, which it will distribute wholesale, and retail via its online store. BioGeron's slogan is "Nature and Science to Enhance and Extend Life." Its product lines are derived from natural ingredients and produced and packaged to the highest standards in the industry, at FDA inspected facilities that are FDA-GMP certified and compliant. According to the Nutrition Business Journal, the nutraceutical industry in 2009 had sales in excess of $108 Billion.

BioGeron, Inc. delivered on December 1st its first product from its Life Extenz Plus brand, Super Krill. Shipments of Super Krill have commenced and revenue activity will be reported to stockholders on a regular basis. Other products will be announced soon as they are ready for sale and distribution on a wholesale and retail basis.

It is also expected that the tentative agreement for the acquisition of Health & Wellness Partners and its products and expertise will be finalized by the end of the year.

For more information about BioGeron, Inc. and its products, please visit the company's website at www.BioGeronInc.com or call 800-279-7550.

About Angel Acquisition Corp. and BioGeron, Inc.

Angel Acquisition Corp. is a diversified asset management company, incorporated in Nevada, that acquires and/or develops profitable companies with an emphasis on health, nutraceutical, real estate and financial service markets. It recently expanded its investment portfolio with the addition of BioGeron, Inc., a bio-nutraceutical manufacturer and distributor. Angel Acquisition Corp. investment portfolio expands by either obtaining a majority-equity position of a company or internally developing profitable enterprises. This strategy provides Angel Acquisition Corp. the ability to experience growth through diverse holdings. It recently changed its name to BioGeron, Inc. For more information, visit http://www.angelacquisitions.com.

BioGeron, Inc. is incorporated in Nevada and an early stage bio-nutraceutical supplement manufacturer, wholesaler and retailer. It is a part of the Nutraceutical Industry, which in 2009 had sales in excess of $108 Billion according to the Nutrition Business Journal. The BioGeron product theme is "Nature and Science to Enhance and Extend Life." 

Safe Harbor Statement:
This press release contains certain forward-looking statements. These forward-looking statements can generally be identified as such because the context of the statement will include words such as BioGeron, Inc. "plans," "expects," "should," "believes," "anticipates" or words of similar importance. Stockholders, potential investors and other readers are cautioned that these forward-looking statements are predictions based only on current information and expectations that are inherently subject to risks and uncertainties that could cause future events or results to differ materially from those set forth or implied by the forward-looking statements. Certain of those risks and uncertainties are discussed in our filings with the Securities and Exchange Commission, including our annual report on Form 10-K and quarterly reports on Form 10-Q. These forward-looking statements are only made as of the date of this press release and BioGeron, Inc. does not undertake any obligation to publicly update such forward-looking statements to reflect subsequent events or circumstances.

Contact Information:

Contact:
Investor Relations
Gary Patterson
ir@BioGeronInc.com
714-369-2933